» Articles » PMID: 31843453

Efficient Gene Silencing by Adenine Base Editor-Mediated Start Codon Mutation

Overview
Journal Mol Ther
Publisher Cell Press
Date 2019 Dec 18
PMID 31843453
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Traditional CRISPR/Cas9-based gene knockouts are generated by introducing DNA double-strand breaks (DSBs), but this may cause excessive DNA damage or cell death. CRISPR-based cytosine base editors (CBEs) and adenine base editors (ABEs) can facilitate C-to-T or A-to-G exchanges, respectively, without DSBs. CBEs have been employed in a gene knockout strategy: CRISPR-STOP or i-STOP changes single nucleotides to induce in-frame stop codons. However, this strategy is not applicable for some genes, and the unwanted mutations in CBE systems have recently been reported to be surprisingly significant. As a variant, the ABE systems mediate precise editing and have only rare unwanted mutations. In this study, we implemented a new strategy to induce gene silencing (i-Silence) with an ABE-mediated start codon mutation from ATG to GTG or ACG. Using both in vitro and in vivo model systems, we showed that the i-Silence approach is efficient and precise for producing a gene knockout. In addition, the i-Silence strategy can be employed to analyze ~17,804 human genes and can be used to mimic 147 kinds of pathogenic diseases caused by start codon mutations. Altogether, compared to other methods, the ABE-based i-Silence method is a safer gene knockout strategy, and it has promising application potential.

Citing Articles

gene mutation through CRISPR RNA-guided base editing weakens bacterial virulence and immune evasion.

Liu X, Huang L, Ye Y, Wang H, Tang M, He F Virulence. 2025; 16(1):2451163.

PMID: 39843407 PMC: 11759621. DOI: 10.1080/21505594.2025.2451163.


In vivo base editing extends lifespan of a humanized mouse model of prion disease.

An M, Davis J, Levy J, Serack F, Harvey J, Brauer P Nat Med. 2025; .

PMID: 39810005 DOI: 10.1038/s41591-024-03466-w.


From bench to bedside: cutting-edge applications of base editing and prime editing in precision medicine.

Xu W, Zhang S, Qin H, Yao K J Transl Med. 2024; 22(1):1133.

PMID: 39707395 PMC: 11662623. DOI: 10.1186/s12967-024-05957-3.


Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance.

Wellhausen N, Baek J, Gill S, June C Nat Rev Cancer. 2024; 24(9):614-628.

PMID: 39048767 DOI: 10.1038/s41568-024-00723-5.


Comprehensive analysis of the editing window of C-to-T TALE base editors.

Feola M, Pulicani S, Tkach D, Boyne A, Hong R, Mayer L Sci Rep. 2024; 14(1):12870.

PMID: 38834632 PMC: 11150444. DOI: 10.1038/s41598-024-63203-8.


References
1.
Ihry R, Worringer K, Salick M, Frias E, Ho D, Theriault K . p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med. 2018; 24(7):939-946. DOI: 10.1038/s41591-018-0050-6. View

2.
Liu Z, Lu Z, Yang G, Huang S, Li G, Feng S . Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing. Nat Commun. 2018; 9(1):2338. PMC: 6002399. DOI: 10.1038/s41467-018-04768-7. View

3.
Pagnamenta A, Murakami Y, Anzilotti C, Titheradge H, Oates A, Morton J . A homozygous variant disrupting the PIGH start-codon is associated with developmental delay, epilepsy, and microcephaly. Hum Mutat. 2018; 39(6):822-826. PMC: 6001798. DOI: 10.1002/humu.23420. View

4.
Bae S, Park J, Kim J . Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics. 2014; 30(10):1473-5. PMC: 4016707. DOI: 10.1093/bioinformatics/btu048. View

5.
Lee C, Jo D, Hwang G, Yu J, Kim J, Park S . CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors. Mol Ther. 2019; 27(8):1364-1371. PMC: 6698196. DOI: 10.1016/j.ymthe.2019.05.013. View